House Bill 420, introduced in Maryland on March 10, 2025, aims to enhance the safety of students in nonpublic schools by allowing school personnel to administer emergency epinephrine to students experiencing anaphylaxis. This legislation addresses the critical need for timely medical intervention in life-threatening allergic reactions, which can occur unexpectedly and may affect students who have not been previously identified as having allergies.

The bill outlines several key provisions. It permits nonpublic schools to establish policies that authorize trained personnel to administer emergency epinephrine, regardless of whether a student has a known allergy or a prescription for the medication. The proposed policy must include training for school staff on recognizing the signs of anaphylaxis, procedures for administering the medication, and follow-up emergency protocols. Additionally, schools are required to notify parents or guardians about the policy at the start of each school year and ensure ongoing oversight by a licensed health care practitioner.

Notably, the bill includes a liability protection clause for school personnel who administer epinephrine in good faith, shielding them from legal repercussions except in cases of willful or gross negligence. This provision aims to encourage staff to act swiftly in emergencies without fear of legal consequences.

The introduction of House Bill 420 has sparked discussions among educators, parents, and health professionals. Supporters argue that the bill is a necessary step to protect students and ensure that schools are prepared for medical emergencies. Critics, however, express concerns about the adequacy of training for school personnel and the potential for misuse of the medication.

The implications of this bill are significant, as it not only addresses immediate health concerns but also reflects a growing recognition of the need for comprehensive allergy management in schools. If passed, House Bill 420 could set a precedent for similar legislation in other states, potentially leading to improved safety standards for students with allergies nationwide. The bill is currently under review, with further discussions anticipated in the coming weeks as stakeholders weigh the benefits and challenges of its implementation.